ImmunityBio, Inc. (NASDAQ:IBRX) is one of the Best American Penny Stocks to Buy According to Analysts. On July 8, ImmunityBio, Inc. (NASDAQ:IBRX) announced that the UK’s Medicines and Healthcare ...

A WHO-Listed Authority designation signifies that an agency has undergone rigorous performance evaluation, using WHO’s ...

Patients will receive medicines 3-6 months faster under 10-Year Health Plan, as regulators set out plans: United Kingdom Thursday, August 7, 2025, 13:00 Hrs [IST] The UK Medicines ...

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its responses to the consultation on Medical Device ...

Under a joint information sharing agreement, pharmaceutical companies will be invited to register early with the MHRA and ...

CAMBRIDGE, MA/ ACCESS Newswire/ February 28, 2025/ Moderna, Inc. today announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for ...

As the Independent reports, the UK Medicines and Healthcare products Regulatory Agency (MHRA) is asking residents to submit their own experiences with glucagon-like peptide-1 (GLP-1) receptor ...

Filament Health has collaborated with University College London (UCL) in the UK to provide its botanical psilocybin drug candidate, PEX010, for two Phase II research studies. These trials, approved by ...

NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.